EP4743104A1 - Small proteins for use as senolytic and senomorphic agents - Google Patents
Small proteins for use as senolytic and senomorphic agentsInfo
- Publication number
- EP4743104A1 EP4743104A1 EP24743797.3A EP24743797A EP4743104A1 EP 4743104 A1 EP4743104 A1 EP 4743104A1 EP 24743797 A EP24743797 A EP 24743797A EP 4743104 A1 EP4743104 A1 EP 4743104A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- senomorphic
- senolytic
- agents
- small proteins
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23382726.0A EP4491190A1 (en) | 2023-07-14 | 2023-07-14 | Small proteins for use as senolytic and senomorphic agents |
| PCT/EP2024/069867 WO2025016917A1 (en) | 2023-07-14 | 2024-07-12 | Small proteins for use as senolytic and senomorphic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4743104A1 true EP4743104A1 (en) | 2026-05-20 |
Family
ID=87378036
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP23382726.0A Withdrawn EP4491190A1 (en) | 2023-07-14 | 2023-07-14 | Small proteins for use as senolytic and senomorphic agents |
| EP24743797.3A Pending EP4743104A1 (en) | 2023-07-14 | 2024-07-12 | Small proteins for use as senolytic and senomorphic agents |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP23382726.0A Withdrawn EP4491190A1 (en) | 2023-07-14 | 2023-07-14 | Small proteins for use as senolytic and senomorphic agents |
Country Status (2)
| Country | Link |
|---|---|
| EP (2) | EP4491190A1 (en) |
| WO (1) | WO2025016917A1 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022245209A2 (en) * | 2021-05-18 | 2022-11-24 | Rijksuniversiteit Te Groningen | Nanopore proteomics |
-
2023
- 2023-07-14 EP EP23382726.0A patent/EP4491190A1/en not_active Withdrawn
-
2024
- 2024-07-12 EP EP24743797.3A patent/EP4743104A1/en active Pending
- 2024-07-12 WO PCT/EP2024/069867 patent/WO2025016917A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025016917A1 (en) | 2025-01-23 |
| EP4491190A1 (en) | 2025-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE439863T1 (en) | OPHTHALMIC PARASYMPATHIC STIMULANT AND ANTI-INFLAMMATORY COMPOSITIONS FOR USE IN THE TREATMENT OF PRESBYOPIA | |
| EP4157888A4 (en) | MODIFIED PROTEINS AND PROTEIN DEGRADERS | |
| EP4365199A4 (en) | CD16 ANTIBODIES AND THEIR USE | |
| ECSP088758A (en) | METHODS TO REDUCE PROTEIN AGLOMERATION | |
| DE602004021037D1 (en) | PHOSPHORORGANIC INDAZONE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS | |
| EP4257605A4 (en) | ANTI-TSLP NANOBODY AND USE THEREOF | |
| ATE447570T1 (en) | PYRIMIDENE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS AND THEIR USE IN THE TREATMENT OF PAIN | |
| ATE484201T1 (en) | USE OF BETA-CRYPTOXANTHIN | |
| DE602005004902D1 (en) | Artificial protein, method for absolute quantification of proteins and its use | |
| EP3978612C0 (en) | METHOD FOR THE QUANTITATIVE CO-EXPRESSION OF MULTIPLE PROTEINS IN VITRO AND ITS APPLICATION | |
| EP3950720A4 (en) | FUSION PROTEIN AND USE THEREOF | |
| EP4442698A4 (en) | MODIFIED AAV CAPSID PROTEIN AND USE THEREOF | |
| EP4188410A4 (en) | CHIMERIC PROTEINS AND METHODS OF USE FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | |
| EP4299593A4 (en) | CLDN18.2-ANTIGEN-BINDING PROTEIN AND USE OF IT | |
| EP4512825A4 (en) | COLLAGEN AND ITS USES | |
| EP4322949C0 (en) | ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMORAL AGENTS | |
| EP4222147C0 (en) | Thiadiazolone derivatives and their use as AMPK agonists for the treatment of diabetes and related diseases | |
| DE602005006101D1 (en) | SUBSTITUTED CHINOLINES AND THEIR USE AS INHIBITORS OF MYCOBACTERIA | |
| EP4511394A4 (en) | SIGLEC-8 binding proteins and uses thereof | |
| EP4501314A4 (en) | LIQUID R-KETAMINE PREPARATION AND USE THEREOF | |
| EP4471138A4 (en) | IGA-PROTEASE SHORTIFICATION, FUSION PROTEIN WITH IGA-PROTEASE SHORTIFICATION AND USE OF IT | |
| EP4380608A4 (en) | Leptospiral Virulence-Modulating Proteins and Uses Thereof | |
| EP4446339A4 (en) | ANTIBODIES FOR THE DETECTION AND USE OF RSV PRE-F PROTEIN | |
| EP4277617A4 (en) | COMPOSITIONS FOR SKIN CARE AND USE THEREOF | |
| DE602006009786D1 (en) | USE OF MOLECULES AND METHOD FOR THE TREATMENT OF MCP-1 / CCR2-ASSOCIATED DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |